Abbott Laboratories

Abbott is making a massive $21B bet on cancer diagnostics by acquiring Exact Sciences. This signals Abbott sees diagnostics — specifically cancer screening and precision oncology — as its next major growth vertical on top of an already high-single-digit growth profile.